Brigida Barberio
University of Padua
Quality of lifeInternal medicineOdds ratioRetrospective cohort studyIntensive care medicineTumor necrosis factor alphaAdverse effectVedolizumabInfliximabInflammatory Bowel DiseasesInflammatory bowel diseaseCalprotectinColonoscopyDiseaseCrohn's diseaseMEDLINEAdalimumabUlcerative colitisEosinophilic esophagitisPopulationCoronavirus disease 2019 (COVID-19)In patientDisease activityAnxietyBiosimilarMedicinePandemicGastroenterologyMeta-analysis
113Publications
7H-index
213Citations
Publications 117
Newest
#1Brigida Barberio (UNIPD: University of Padua)H-Index: 7
#2Edoardo Savarino (UNIPD: University of Padua)H-Index: 60
Last. Alexander C. Ford (St James's University Hospital)H-Index: 86
view all 0 authors...
ABSTRACT null Objectives null There are several licensed drugs for irritable bowel syndrome (IBS) that have proven efficacy in randomized controlled trials (RCTs) but placebo response rates are high. We conducted a systematic review and meta-analysis of licensed drugs to estimate magnitude of placebo response rate according to Food and Drug Administration (FDA)-recommended endpoints, and to assess how this varies with stringency of the endpoint used to define response. null Methods null We searc...
Source
#1Brigida Barberio (UNIPD: University of Padua)H-Index: 7
#2Davide Massimi (UNIPD: University of Padua)H-Index: 3
Last. Edoardo Savarino (UNIPD: University of Padua)H-Index: 60
view all 0 authors...
ABSTRACT null Background & Aims null Although the association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC) is well recognised, uncertainties remain about the magnitude of this problem. We conducted a systematic review and meta-analysis assessing prevalence of PSC in IBD to investigate whether type of IBD, how presence of PSC was defined, sex, disease extent or location, time period, or geographical location influenced prevalence. null Methods null MEDLINE, EM...
Source
#1Brigida Barberio (UNIPD: University of Padua)H-Index: 7
#2Edoardo Savarino (UNIPD: University of Padua)H-Index: 60
Last. Fabiana Zingone (UNIPD: University of Padua)H-Index: 22
view all 9 authors...
Background/aims null Current literature is lacking in studies comparing the incidence of adverse events (AEs) in patients with inflammatory bowel diseases (IBD) treated with adalimumab (ADA) or vedolizumab (VDZ) in a real-life scenario. Therefore, our primary aim was to compare the AEs occurring in patients taking ADA to those of patients taking VDZ. null Methods null In this single center study, data on AEs from IBD patients who underwent treatment with ADA and VDZ were retrospectively collecte...
Source
#1Matteo Ghisa (UNIPD: University of Padua)H-Index: 8
#2Giorgio Laserra (UNIPD: University of Padua)H-Index: 3
Last. Edoardo Savarino (UNIPD: University of Padua)H-Index: 60
view all 15 authors...
Abstract Background An association has been reported between achalasia and eosinophilic esophagitis (EoE). We performed a retrospective study of high-resolution manometry (HRM) patterns in a large cohort of patients with EoE. Material and methods We collected data from consecutive patients with a new diagnosis of EoE from 2012 through 2019 undergoing HRM during the initial assessment at different centers in Italy. Demographic, clinical, endoscopic and histological characteristics were recorded a...
4 CitationsSource
#1Brigida Barberio (UNIPD: University of Padua)H-Index: 7
#2Ciaran Judge (St James's University Hospital)H-Index: 1
Last. Alexander C. Ford (University of Leeds)H-Index: 86
view all 4 authors...
Summary null Background null Functional constipation is a common functional bowel disorder in the community, which has a varying prevalence across cross-sectional surveys. We did a contemporaneous systematic review and meta-analysis of studies using comparable methodology and all iterations of the Rome criteria to estimate the global prevalence of functional constipation. null Methods null In this systematic review and meta-analysis, we searched MEDLINE, Embase, and Embase Classic from Jan 1, 19...
1 CitationsSource
#2Fabiana ZingoneH-Index: 22
Last. Edoardo SavarinoH-Index: 60
view all 10 authors...
Source
#1Lorenzo Bertani (UniPi: University of Pisa)H-Index: 14
#2Brigida Barberio (UNIPD: University of Padua)H-Index: 7
Last. Maria Gloria MumoloH-Index: 12
view all 13 authors...
During the coronavirus disease 2019 (COVID-19) pandemic, immunomodulatory therapies and hospital admission were suspected to increase the risk of infection. Nevertheless, patients with inflammatory bowel diseases (IBD) treated with intravenous (i.v.) biologics had to move to hospitals for drug infusion. We investigated the impact of hospitalisation in patients with IBD. We conducted a survey including consecutive IBD patients initially in clinical and biochemical remission treated with biologics...
Source
#1Brigida Barberio (UNIPD: University of Padua)H-Index: 7
#2Linda Cingolani (UNIPD: University of Padua)H-Index: 2
Last. Maria Giulia Demarzo (UniGe: University of Genoa)H-Index: 3
view all 16 authors...
Background:Adalimumab is an effective and safe biological drug for the treatment of inflammatory bowel disease (IBD). Nowadays, several biosimilar agents are available, but data regarding their eff...
Source
#1Brigida Barberio (UNIPD: University of Padua)H-Index: 7
#2Jonathan P Segal (Imperial College Healthcare)H-Index: 11
Last. Alexander C. Ford (St James's University Hospital)H-Index: 86
view all 6 authors...
BACKGROUND 5-aminosalicylates (5-ASAs) are the mainstay of treatment for ulcerative colitis (UC). The optimum preparation, dose, and route of administration for UC remains unclear. We conducted a network meta-analysis to examine this issue. METHODS We searched MEDLINE, EMBASE, EMBASE Classic, and the Cochrane central register of controlled trials from inception to December 2020. We included randomised controlled trials (RCTs) comparing oral, topical, or combined oral and topical 5-ASAs, with eac...
2 CitationsSource
#1Matteo Ghisa (UNIPD: University of Padua)H-Index: 8
#2Ilenia BarbuscioH-Index: 2
Last. Edoardo SavarinoH-Index: 60
view all 4 authors...
Source